Inese P.
- Country
- Latvia
- Department
- General Medicine
Research Overview
- Phase 3 Double-Blind, Placebo-Controlled Trial Evaluating Plozasiran Efficacy and Safety in Adults with Severe Hypertriglyceridemia
- Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis (SHASTA-5 Study)
Data & Insights
Has run more than one trial at 14 of 103 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in studying severe hypertriglyceridemia (SHTG), a serious metabolic condition characterized by abnormally high levels of triglycerides in the blood. Their research focuses on evaluating innovative therapeutic approaches for managing this disorder.
- Lipid Metabolism Disorders
- Triglyceride Level Management
- Cardiovascular Risk Factors
This research area encompasses the study of therapeutic interventions aimed at reducing fasting serum triglyceride levels in adult patients.
Therapeutic Development
The investigator's work centers on evaluating novel therapeutic agents for metabolic disorders. Their expertise includes assessing the efficacy of emerging treatments for patients with severe lipid disorders.
- Novel Therapeutic Approaches
- Treatment Efficacy Assessment
- Patient Response Evaluation
The research focuses on developing and validating new treatment options for patients with severe metabolic conditions.
Clinical Management
The investigator's clinical interests include the comprehensive management of patients with severe lipid disorders. Their work involves evaluating treatment outcomes in adult populations with challenging metabolic conditions.
- Patient Care Protocols
- Treatment Monitoring
- Clinical Outcomes Assessment
This research area focuses on optimizing clinical care strategies for patients with severe metabolic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.